ORTHOPEDIATRICS CORP - Class A common stock, $0.00025 par value (KIDS) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2017 to Q4 2025

Type / Class
Equity / Class A common stock, $0.00025 par value
Symbol
KIDS on Nasdaq
Shares outstanding
25,086,311
Price per share
$17.76
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
16,501,828
Total reported value
$305,775,919
% of total 13F portfolios
0%
Share change
-317,065
Value change
-$6,454,981
Number of holders
110
Price from insider filings
$17.76
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ORTHOPEDIATRICS CORP - Class A common stock, $0.00025 par value (KIDS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
INTEGRATED CORE STRATEGIES (US) LLC 5.5% $25,768,856 1,390,656 Millennium Management LLC 29 Oct 2025
BlackRock, Inc. 5% $26,436,748 1,230,784 BlackRock, Inc. 30 Jun 2025
BROWN CAPITAL MANAGEMENT LLC 4.3% -35% $20,035,007 -$10,919,822 1,081,220 -35% Brown Capital Management, LLC 30 Sep 2025

As of 30 Sep 2025, 110 institutional investors reported holding 16,501,828 shares of ORTHOPEDIATRICS CORP - Class A common stock, $0.00025 par value (KIDS). This represents 66% of the company’s total 25,086,311 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of ORTHOPEDIATRICS CORP - Class A common stock, $0.00025 par value (KIDS) together control 59% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BROWN ADVISORY INC 7.6% 1,894,705 +17% 0.05% $35,108,886
BlackRock, Inc. 4.8% 1,216,574 -2.1% 0% $22,543,117
MORGAN STANLEY 4.4% 1,111,448 -9.3% 0% $20,595,135
BRAIDWELL LP 4.4% 1,107,770 0% 0.61% $20,526,978
BROWN CAPITAL MANAGEMENT LLC 4.3% 1,081,220 -31% 0.83% $20,035,007
WELLINGTON MANAGEMENT GROUP LLP 4.1% 1,024,555 -0.21% 0% $18,985,004
VANGUARD GROUP INC 3.8% 961,330 +1.1% 0% $17,813,445
MILLENNIUM MANAGEMENT LLC 3.8% 943,655 +21% 0.01% $17,485,927
Granahan Investment Management, LLC 3% 759,951 -21% 0.58% $14,081,892
DIMENSIONAL FUND ADVISORS LP 2.9% 719,831 -1.5% 0% $13,338,081
AWM Investment Company, Inc. 2.2% 549,949 +3.5% 0.96% $10,190,555
MARSHALL WACE, LLP 1.8% 444,320 +6% 0.01% $8,233,250
STATE STREET CORP 1.7% 427,184 -0.29% 0% $7,915,720
GEODE CAPITAL MANAGEMENT, LLC 1.7% 417,852 +2% 0% $7,743,813
Prosight Management, LP 1.2% 308,707 +319% 1.4% $5,720,341
WASATCH ADVISORS LP 1.2% 304,111 -3.7% 0.03% $5,635,177
RIVERBRIDGE PARTNERS LLC 1.2% 293,864 -8.5% 0.09% $5,445,296
DEERFIELD MANAGEMENT COMPANY, L.P. 0.77% 194,109 +1153% 0.06% $3,596,840
NEW YORK STATE COMMON RETIREMENT FUND 0.76% 191,066 -57% 0% $3,540,453
PARADIGM CAPITAL MANAGEMENT INC/NY 0.72% 181,000 +6% 0.15% $3,353,930
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC 0.72% 179,410 -3% 0.04% $3,324,467
NORTHERN TRUST CORP 0.7% 175,023 -2.6% 0% $3,243,175
KENNEDY CAPITAL MANAGEMENT LLC 0.66% 165,513 -12% 0.07% $3,066,956
Triodos Investment Management BV 0.53% 132,500 +18% 0.18% $2,453,900
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.52% 131,115 -5.3% 0% $2,429,561

Institutional Holders of ORTHOPEDIATRICS CORP - Class A common stock, $0.00025 par value (KIDS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 429,958 $7,635,663 -$669,841 $17.76 8
2025 Q3 16,501,828 $305,775,919 -$6,454,981 $18.53 110
2025 Q2 16,817,981 $361,248,552 +$2,212,295 $21.48 116
2025 Q1 16,691,588 $411,125,012 +$5,143,009 $24.63 114
2024 Q4 16,501,406 $382,504,159 +$773,471 $23.18 107
2024 Q3 16,333,743 $442,837,473 +$1,584,968 $27.11 121
2024 Q2 16,242,247 $467,138,707 +$10,095,978 $28.76 120
2024 Q1 15,892,946 $463,440,165 -$12,906,846 $29.16 117
2023 Q4 16,261,994 $528,667,001 -$251,450 $32.51 126
2023 Q3 16,271,554 $521,018,497 +$6,205,213 $32.00 115
2023 Q2 15,984,589 $701,031,443 -$10,062,157 $43.85 120
2023 Q1 16,213,938 $717,721,563 +$13,280,226 $44.29 120
2022 Q4 15,969,552 $634,638,489 -$20,370,351 $39.73 117
2022 Q3 15,319,596 $706,913,920 +$7,022,250 $46.14 120
2022 Q2 15,147,316 $653,533,661 +$9,822,525 $43.15 112
2022 Q1 14,882,764 $803,548,443 +$23,227,965 $53.99 121
2021 Q4 14,446,519 $864,710,320 -$43,598,809 $59.86 123
2021 Q3 14,787,776 $968,927,802 -$16,120,535 $65.51 140
2021 Q2 15,040,814 $950,122,354 +$34,742,154 $63.18 136
2021 Q1 14,650,983 $714,225,765 -$10,678,703 $48.75 122
2020 Q4 15,132,644 $624,376,779 +$44,734,958 $41.25 130
2020 Q3 13,957,347 $640,952,762 +$41,183,608 $45.92 122
2020 Q2 13,071,781 $571,934,696 +$88,263,492 $43.76 127
2020 Q1 11,071,736 $438,826,875 +$57,686,504 $39.64 104
2019 Q4 9,512,953 $446,965,037 +$84,907,154 $46.99 104
2019 Q3 7,509,308 $264,801,326 +$8,203,360 $35.26 88
2019 Q2 7,203,561 $280,872,895 +$1,251,778 $39.00 98
2019 Q1 7,148,503 $316,165,724 +$23,434,585 $44.23 93
2018 Q4 6,630,503 $231,241,733 +$50,275,283 $34.88 75
2018 Q3 5,186,095 $189,981,535 +$5,589,115 $36.64 63
2018 Q2 5,138,887 $136,915,101 +$18,977,050 $26.64 55
2018 Q1 4,514,822 $67,993,229 +$3,724,248 $15.06 46
2017 Q4 4,158,182 $79,791,894 +$79,791,894 $19.19 49